Company ProfilePremium

Hong Kong Ferry (Holdings) Company Limited

Company Profile Analysis

Ticker: 0050.HK

ESOMAR 23 Corporate BadgeISO Certifications Badge
Hong Kong Ferry (Holdings) Company Limited - Company showcase

Year Founded & Workforce

1923

363 Employees

Hong Kong Ferry (Holdings) Company Limited logo

Hong Kong Ferry (Holdings) Company Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Hong Kong Ferry (Holdings) Company Limited Overview

Hong Kong Ferry (Holdings) is a century-old Hong Kong conglomerate. It began as the territory's largest franchised ferry operator and has turned into a cash-rich property investor that is affiliated with, and about one-third owned by, the Henderson Land group. Its ferry legacy now consists of the sole licensed dangerous-goods vehicular ferry service (North Point–Kwun Tong), the Hong Kong Shipyard in Tsing Yi, and harbour cruises. Profits mainly come from rent on community podium malls in Tai Kok Tsui, Fanling, Yau Tong and Tsuen Wan, from a youth hostel converted from its "The Symphonie" redevelopment, and from interest on more than HKD 2.2 billion of cash. Since 2022 the company has built a premium healthcare and medical-aesthetics business (AMOUR Aesthetic, Total HealthCare, Alliance Medical Centre), which reached break-even in H1 2026. The company has no debt. Its shares trade at about 0.23× book value and below its net cash per share, which makes it a classic Hong Kong "deep-value, low-turnover" family-affiliated holding company.


The company's own description

The FY2025 results announcement and the H1 2026 interim announcement describe operations in three major segments: (1) property development and investment, (2) ferry, shipyard and related operations, and (3) medical, healthcare and beauty services. Securities investment is a fourth, smaller reportable line. Management says the group has operated ferry services in Hong Kong for more than a century and is currently the only Hong Kong company offering vehicular ferry and dangerous-goods vehicular ferry services. It moved into residential property development in the early 2000s and launched its medical specialist and beauty business in 2022. Management presents the three core segments as complementary, diversifying risk and supporting long-term value (2025 Results Announcement, "Development Strategy and Principal Risks"). Its press releases describe the group as having "transformed itself from a ferry and shipyard focused business into an integrated conglomerate" (Gabriel Lee, General Manager, FY2023 to FY2025 releases).

Reportable segments (as defined in the FY2025 accounts)

Property development: development and sale of properties. There was no external revenue in FY2023 to FY2025. The main exposure is the 50% joint venture in "The Royale" (Tuen Mun), which is equity-accounted, so its profits appear as share of JV profits.

Property investment: rental income from shops, commercial arcades and, from June 2025, the "TN Residence" youth hostel.

Ferry, shipyard and related operations: the dangerous-goods vehicular ferry service, ship repair and maintenance at Hong Kong Shipyard, and sales of goods on cruise vessels (Harbour Cruise – Bauhinia).

Medical, healthcare and beauty services: AMOUR Aesthetic (medical aesthetics), Total HealthCare (pain management and chiropractic centres), physiotherapy, and medical-equipment leasing. The H Zentre specialist centre (Alliance Medical Centre) is held through a joint venture.

Securities investment: dividend, interest and fair-value income from listed securities.

Others (unallocated): bank interest income, management fees, air-conditioning charges and corporate costs.

Revenue model

Revenue typeSegmentNatureApprox. FY2025 scale (HKD Mn)
Recurring rental (leases)Property investmentContracted lease income plus turnover rent (turnover rent was HKD 2.4M in FY2025)193.9 segment external revenue; gross rental about 147
Service fees (transport)FerryRegulated fares set by the Transport DepartmentIncluded in 165.8
Service fees (ship repair)ShipyardProject and job-based repair and maintenanceIncluded in 165.8
Product salesCruiseFood and beverage, goods on vesselsIncluded in 165.8
Consumer servicesMedical/beautyTreatment fees and prepaid packages (contract liabilities)57.1
Equipment leasingMedicalRental of jointly purchased medical devices to hospitals and doctors—
Investment incomeSecurities / OthersDividends, bank interest, FVPL gainsInterest income 64.3; dividends 7.0
Property salesDevelopmentLumpy unit sales, now mostly through the JVNil at group revenue level in FY2025

The model is therefore mostly service and rental income, with a substantial financial income layer. There is no subscription or licensing income.

Value-chain position, customers and end-markets

HKF sits in four positions in the value chain. It is a landlord and asset owner for community retail; a regulated monopoly-like transport utility (dangerous goods) whose main customers are oil-product distributors and gas suppliers serving Hong Kong Island, including deliveries of flammable gases to hospitals; a marine services provider (repair and maintenance for local vessel owners); and a B2C premium healthcare provider. Customers include retail tenants (supermarkets, F&B, banks, services), the Tung Wah Group of Hospitals (lessee of TN Residence), fuel logistics operators, local shipowners, tourists and local cruise passengers, and affluent individual patients. Essentially all revenue is earned in Hong Kong.

Independent characterisation

Economically, HKF is a cash box with a property portfolio attached. At 30 June 2026, cash (HKD 2,205M) plus investment properties (HKD 4,549M) made up about 87% of total assets (HKD 7,713M). Operating businesses outside property are small: the ferry and shipyard segment lost money in each of FY2023 to FY2025, and the medical segment only turned profitable in H1 2026. Earnings quality depends heavily on three external variables: HIBOR/deposit rates (interest income fell from HKD 99M in FY2023 to HKD 64M in FY2025), Hong Kong retail rental conditions, and property revaluations. Strategic direction is shaped by the Henderson Land relationship. Henderson-linked directors chair the board, related-company balances run in both directions, and the group's stated purpose has historically included sharing synergies with the Henderson Land group.

Strategy

Stated strategic themes (FY2025 Annual Results and 2026 Interim, paraphrased)

  1. Diversified, mutually reinforcing three-pillar model. Property, ferry and shipyard, and medical are run as complementary businesses to spread risk.

  2. Defensive community-retail leasing. The focus is podium malls serving residents' daily needs, which management considers less exposed to tourist-pattern shifts and northbound cross-border consumption. The company flexes leasing terms and optimises tenant mix.

  3. Opportunistic acquisitions at cyclical lows. Management notes that commercial valuations have fallen sharply, creating long-term value opportunities. It will invest "only when returns are attractive and risks are manageable" (company phrasing, abridged).

  4. Cost recovery in the ferry business. The company will keep negotiating fare increases with the government, recognising that EV adoption will structurally erode fuel-truck volumes.

  5. Event economy and leisure innovation. Themed cruises, classic vehicular-ferry cruises, pet-friendly cruises and the Pierside Run are aligned with the government's "Mega Event Economy" and yacht-hub policies.

  6. Shipyard diversification. The company is assessing a change of use for part of the shipyard land.

  7. A premium healthcare ecosystem. The aim is to serve high-end, non-hospital clients on quality rather than price, insulating the business from GBA cross-border price competition and from private hospitals' outpatient discounting. The group will add equipment, recruit doctors and specialists, and partner with institutions.

  8. "Putting People First" sustainability goal. Initiatives include the youth hostel partnership with TWGHs and harbourfront public amenities.

Initiatives in the last 24 months

DateInitiativeTypeDetail
2H 2024Medical equipment leasingNew businessCo-investment with specialists
12 Mar 2025Symphonie whole-block lease MOUAsset repositioning262 units leased to a non-profit at market rent
12 Apr 2025Dangerous-goods ferry fare riseCost recoveryNorth Point–Kwun Tong route
Jun 2025TN Residence opensSocial/commercialGovernment youth hostel subsidy scheme
2,025North Point East Pier bicycle parkingCommunityPartnership with a local bicycle company
Aug 2025Physiotherapy centre, H ZentreHealthcare expansionWith a fitness partner
Sep 2025Ferry fare applicationCost recoverySubmitted to the Transport Department
30 Sep 2025Tai Hung Fai acquisitionAcquisitionHKD 260M; shop reconfiguration, LED signage
Nov 2025Alliance Medical Centre rebrandBrandDual-centre model
Jan 2026Third Total HealthCare centreExpansionTsuen Wan
2025–2026AMOUR floor-area expansionCapacityMira Place
Apr 2026Symphonie car park opensMonetisationShort-term parking leases
27 Jun 2026New ferry faresCost recoveryExpected to cut H2 2026 losses
Jul 2026Pet-friendly Bauhinia cruiseProductLeisure/event economy
2,026Pierside Run 2026Cross-segmentCombines ferry and healthcare
OngoingShipyard partial land-use conversion studyAsset optimisationFeasibility stage

Guidance and targets

Management gives no quantitative guidance or medium-term financial targets. Qualitatively, it expects revenue in H2 2026 to come primarily from property rentals and bank interest income. It also expects the ferry loss to narrow after the June 2026 fare rise, and expects the medical business "to become profitable", which it achieved in H1 2026. Cost programmes with targets: none disclosed.

Products & Services

Property investment portfolio

AssetLocationTypeStatus / KPINotes
Metro6 (commercial arcade)Tai Kok Tsui, KowloonPodium retail100% let at Dec 2024, Dec 2025 and Jun 2026Community mall
Metro Harbour PlazaTai Kok Tsui, KowloonLarge residential podium mallOccupancy 93% (Dec 2024), 94% (Dec 2025), 93% (Jun 2026)Hosts a Total HealthCare centre
Shining Heights (arcade)Tai Kok Tsui, KowloonPodium retailOccupancy 95%, then 81%, then 70% (Dec 2024 to Jun 2026)Weakest asset, still declining
The Spectacle (arcade)Yau Tong / Kowloon East area (per company naming; exact address not in reviewed filings)Podium retail100%, then 91%, then 91%—
Green Code Plaza1 Ma Sik Road, Fanling, NTLarge podium mall (four 29-storey residential towers above)86%, then 98%, then 94%Largest Fanling estate of the past decade per company profile
Tai Hung Fai (Tsuen Wan) Centre, Portion A G/F55 Chung On Street, Tsuen WanStreet shops plus signage and LED advertisingAcquired 30 Sep 2025 for HKD 260M; about 12,700 sq ft GFA; 100% letA financial institution was introduced as tenant in 2026
TN Residence (The Symphonie)280 Tung Chau Street, Cheung Sha Wan262 residential units (about 100,698 sq ft GFA) leased whole as a youth hostelRent from Jun 2025, adjusted by hostel occupancy; car park opened Apr 2026Operated by Tung Wah Group of Hospitals under the government's youth hostel subsidy scheme; URA-related site
The Royale leftover stock (JV)8 Castle Peak Road – Castle Peak Bay, Tuen Mun33 unsold units (Jun 2026); 10 units, 106 car spaces and 18 motorcycle spaces on short-term leases1,748 units sold and delivered50/50 JV with the Empire Group

Investment property carrying value: HKD 2,488.7M (Dec 2023), HKD 2,495.8M (Dec 2024), HKD 4,555.5M (Dec 2025), HKD 4,548.9M (Jun 2026). The FY2025 step-up reflects the Symphonie reclassification from inventory, the Tai Hung Fai acquisition and a HKD 50.3M revaluation gain.

Gross rental income: arcades about HKD 122M (FY2023), arcades about HKD 125M (FY2024), arcades plus shops plus hostel about HKD 147M (FY2025, +17%), and HKD 97M in H1 2026 (+60% YoY).

Property development

ProjectStatusEconomics
The Royale (TMTL 547)Completed; 1,748 units delivered50% JV. Profits recognised mainly in FY2022 (group profit HKD 1.3B); a one-off post-tax construction-cost adjustment boosted FY2025 JV share to HKD 174.6M
The SymphonieCompleted Nov 2023; converted to rental in 2025Reclassified from "completed properties held for sale" to investment property in FY2025
PipelineNo new development site disclosedManagement is "actively seeking" investment opportunities

Ferry, shipyard and related operations

OfferingDescriptionTarget customerPricing modelLatest development
North Point–Kwun Tong dangerous-goods vehicular ferryThe only licensed service carrying fuel trucks and other dangerous-goods vehicles across Victoria Harbour; supplies oil products for Hong Kong Island and flammable gases for hospitals and institutionsFuel and gas distributorsRegulated fares approved by the Transport DepartmentFare rises in Jan 2024, 12 Apr 2025 and 27 Jun 2026
Vehicular ferry serviceThe group remains the only company offering vehicular ferry services (2025 Results)Commercial vehiclesRegulatedClassic Vehicular Ferry Cruise in Victoria Harbour on public holidays
Harbour Cruise – BauhiniaDining and themed harbour cruises from North PointLocals, tourists, eventsTicketed plus F&BPet-friendly dining cruise added Jul 2026
Hong Kong ShipyardTsing Yi North yard of about 200,000 sq ft; synchrolift, one of the largest in Hong Kong; transfer system that can dry-dock up to 10 vessels at once; repair, maintenance, shipbuilding and civil engineeringLocal shipowners, government and commercial fleetsJob/project basisRevenue −12% in FY2025; partial land-use conversion under study
The Pierside Run 2026Cross-segment event combining ferry journeys and healthcarePublicEvent-basedLaunched 2026
Bicycle parking at North Point East PierPartnership with a local bicycle companyPublic—2,025

Medical, healthcare and beauty services

Brand / unitLocationServicesLaunchKPIs
AMOUR Aesthetic (AMOUR medical aesthetic centre)Mira Place, Tsim Sha Tsui (about 12,000 sq ft, since expanded)Skin, body contouring, hair revitalisation under a "Scientific Aesthetics" philosophy; service pledges of no hard selling, genuine authorised products and a 10-day cooling-off period2H 2022FY2024 turnover HKD 32M (+138%); HKD 15M prepaid packages deferred at Dec 2024; HK Emerging Service Brand award Feb 2026
Total HealthCare Health CentresMira Place (TST); Metro Harbour Plaza (Tai Kok Tsui); Tai Hung Fai Centre (Tsuen Wan, trial from Jan 2026)Pain management, chiropractic, sports training, orthopaedic and post-surgical rehabilitation2023/24 onwardsThree centres at Jun 2026
Alliance Medical Centre (formerly Total HealthCare Specialists Centre)H Zentre, TST, plus a second service point at Mira Place in a dual-centre modelCardiology, surgery, orthopaedics, plastic surgery, urology (rheumatology listed in FY2024)1H 2023 (JV); renamed Nov 2025Profitable per management
Physiotherapy centreH Zentre, TSTPhysiotherapy with a fitness-centre partner of more than 20 years' standingAug 2025—
Medical equipment leasing—Devices co-purchased with specialists and leased to hospitals and doctors2H 2024—

Segment revenue: HKD 13.8M (FY2023), HKD 40.1M (FY2024), HKD 57.1M (FY2025), HKD 34.2M (H1 2026).

Securities investment

The group holds a listed securities portfolio, valued at HKD 160.9M within "other financial assets" at Dec 2025 and HKD 158.8M at Jun 2026. Some of it is classified as FVOCI (non-recycling) and some as FVPL. It contributed a profit of HKD 23.9M in FY2025 and a loss of HKD 2.6M in H1 2026, when FVPL marks fell by HKD 5.8M. Individual holdings are not disclosed in the announcements.

Financial Narrative

Sources: audited figures from the 2024 and 2025 Results Announcements for FY2023 to FY2025; FY2021 and FY2022 figures from S&P Global Market Intelligence (StockAnalysis.com) and ET Net, cross-checked against the FY2022 earnings release (Simply Wall St). Blank cells mean the figure was not available from verified sources.

Income statement

Notes:

  • FY2023 underlying profit of about HKD 144M is derived from the FY2024 disclosure that underlying profit of HKD 158M was "approximately 10%" higher.

  • FY2021 and FY2022 JV share uses the S&P "earnings from equity investments" line.

  • The FY2020 base was revenue HKD 208.3M and profit attributable HKD 26.6M (ET Net).

Margins and growth (%)

Underlying EBITDA (analyst-derived) = profit from operations − IP valuation gains + depreciation and amortisation. This gives HKD 151.6M (FY2023), HKD 152.3M (FY2024) and HKD 136.0M (FY2025). Note that it includes bank interest income, which runs through "other revenue" and "Others". Excluding interest income, core operating EBITDA would be about HKD 52M (FY2023), HKD 59M (FY2024) and HKD 72M (FY2025), which shows the improving operating core.

Revenue CAGR: FY2021–FY2025 (4 years) is 15.0%; FY2020–FY2025 (5 years) is 15.5%. Growth decelerated sharply to 1.0% in FY2025 and re-accelerated to 20.5% in H1 2026.

Balance sheet

H1 2026 update (30 Jun 2026): total assets HKD 7,713M; cash HKD 2,205M; investment properties HKD 4,549M; shareholders' funds HKD 7,351M (HKD 20.63 per share); net current assets HKD 2,221M; current ratio 9.4×.

Short- versus long-term debt split: there is no bank debt in any year. Lease liabilities split into current HKD 8.4M and non-current HKD 13.9M (FY2025).

Cash flow: notes and sources

Source: S&P Global Market Intelligence via StockAnalysis.com. These figures are S&P-standardised and may differ from the company's statutory cash-flow presentation, particularly in the classification of time deposits, which explains the large "net change in cash" swings against the stable cash balance. TTM to June 2026: OCF HKD 130.9M, FCF HKD 125.7M.

Ratios

ROIC: 2.37% TTM per S&P. Analyst view: ROIC is not very meaningful for a company where cash is about 29% of equity.

Net debt/EBITDA: not meaningful (net cash).

Interest coverage: profit from operations ÷ lease interest was about 658× (FY2023), 285× (FY2024) and 292× (FY2025). The only interest cost is on leases.

Cash conversion cycle: not meaningful for this business mix. Trade debtors are billed on 7 to 45-day terms, and trade payables were mostly due within one month (HKD 115.6M of HKD 116.6M at Dec 2025).

Commentary on trends, inflections and drivers

Revenue. Revenue rose from HKD 244M to HKD 427M between FY2021 and FY2025. Three contributors drove this:

  • the post-COVID recovery of ferry, shipyard and cruise activity (ferry segment revenue +8% in FY2024);

  • the build-out of the medical business from zero to HKD 57M;

  • incremental rent from Tai Hung Fai (from Q4 2025) and TN Residence (from June 2025).

FY2025's 1% growth masked a 12% fall in shipyard revenue. The company attributed this to fewer Hong Kong-registered ships, owners buying more basic maintenance, and owners shifting work to Mainland yards. The H1 2026 rebound of 20.5% is driven by rent: gross rental income rose 60%.

Profit. Reported profit is dominated by non-recurring items. FY2022's HKD 1.3B came from recognising The Royale JV profits. FY2025's HKD 335M included a one-off post-tax construction-cost adjustment in the same JV, which lifted the JV share to HKD 174.6M against HKD 41.0M in FY2024, plus HKD 50.3M of revaluation gains. Underlying profit (excluding revaluation) was HKD 158M in FY2024 and HKD 284M in FY2025; the FY2025 figure still includes the JV one-off. The cleanest recurring earnings base is probably about HKD 140–160M a year, consistent with H1 2026 underlying profit of HKD 73M. That base faces pressure from falling interest income: bank interest fell from HKD 99.1M (FY2023) to HKD 93.5M (FY2024) to HKD 64.3M (FY2025), and to HKD 29.4M in H1 2026 against HKD 40.0M a year earlier.

Cost base. Administrative expenses rose from HKD 75.0M (FY2023) to HKD 98.2M (FY2024) to HKD 114.6M (FY2025), mainly because of medical-segment staffing. Staff costs went from HKD 114.9M to HKD 140.7M to HKD 143.7M. The medical segment's losses narrowed from HKD 37.8M to HKD 27.6M to HKD 4.4M, and it reached a HKD 1.3M profit in H1 2026, so the cost build is now being absorbed.

Balance sheet. The defining FY2025 change was the shift from inventory to investment property: inventory fell from HKD 1,803M to HKD 75M, and investment property rose from HKD 2,496M to HKD 4,556M. This converted a trading asset into a recurring-income asset and raised the group's exposure to revaluation volatility. Cash has stayed at HKD 1.8–2.2B throughout, even after the HKD 356M special dividend in 2023.

Tax. The effective tax rate dropped to 1.7% in FY2025 because the JV share is post-tax. It normalised to 14.0% in H1 2026 (HKD 13.0M tax, including a HKD 9.9M deferred-tax charge).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

Segment (HKD Mn)FY2023FY2024FY2025

Property development

000

Property investment

170.1172.3193.9

Ferry shipyard and related operations

164.6177.9165.8

Medical healthcare and beauty services

13.840.157.1

Securities investment

6.511.89.4

Others (interest mgmt fees corporate)

103.290.664.4

Total segment revenue

458.3492.7490.5

Of which reported Revenue line

374.6422.9427.3

Of which Other revenue

83.769.863.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment YoY growth (%)

Segment YoY growth (%)FY2024FY2025

Property investment

1.312.5

Ferry shipyard and related

8.0-6.8

Medical healthcare and beauty

191.042.3

Securities investment

80.1-20.2

Others

-12.2-28.9

Segment share of total segment revenue (%)

Segment share of total segment revenue (%)FY2023FY2024

Property investment

37.135.0

Ferry shipyard and related

35.936.1

Medical healthcare and beauty

3.08.1

Securities investment

1.42.4

Others

22.518.4

Revenue by Segment and Revenue by Segment (%)

Segment result (HKD Mn)FY2023FY2024FY2025

Property development

-0.7-9.2-10.4

Property investment (incl. revaluation)

123.776.5119.8

of which valuation gains on IP

42.32.050.3

Property investment ex-revaluation

81.474.569.5

Ferry shipyard and related

-7.6-8.0-20.1

Medical healthcare and beauty

-37.8-27.6-4.4

Securities investment

-2.316.423.9

Others

99.186.957.2

Profit from operations

174.3134.9166.1

Share of associates and JVs

32.641.9175.1

Profit before taxation

206.6176.3340.6

Segment margin (%)

Segment margin (%)FY2023FY2024FY2025

Property investment incl. revaluation

72.744.461.8

Property investment ex-revaluation

47.843.235.8

Ferry shipyard and related

-4.6-4.5-12.1

Medical healthcare and beauty

-274.6-68.9-7.6

Revenue by Segment (Half-Yearly)

Segment (HKD Mn)H1 2025 revenueH1 2026 revenueYoY %H1 2025 resultH1 2026 result

Property development

00—-6.0-0.1

Property investment

82.2123.049.783.669.1

Ferry shipyard and related

73.984.214.0-12.5-9.1

Medical healthcare and beauty

25.534.234.2-3.81.3

Securities investment

5.74.4-23.215.4-2.6

Others

40.130.1-24.936.526.4

Total

227.3275.921.4113.185.1

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (HKD Mn)

244.2280.6374.6422.9427.3

Direct costs (HKD Mn)

164.6179.8234.1258.8264.2

Gross profit (HKD Mn)

79.6100.9140.5164.1163.1

Valuation gains on investment properties (HKD Mn)

75.620.442.32.050.3

Profit from operations (HKD Mn)

——174.3134.9166.1

Share of JVs and associates (HKD Mn)

-31.21,180.032.641.9175.1

Profit before tax (HKD Mn)

138.61,355.9206.6176.3340.6

Taxation (HKD Mn)

——20.815.95.9

Profit for the year (HKD Mn)

——185.9160.4334.7

Profit attributable to shareholders (HKD Mn)

118.21,299.1190.4163.9335.4

Underlying profit (HKD Mn)

——144158284

EPS basic and diluted (HKD)

0.333.650.530.460.94

DPS ordinary (HKD)

0.250.250.250.250.25

DPS special (HKD)

01.00000

DPS total (HKD)

0.251.250.250.250.25

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue growth (%)

17.314.933.512.91.0

Gross margin (%)

32.635.937.538.838.2

Operating margin, profit from ops ÷ revenue (%)

——46.531.938.9

Underlying EBITDA margin (%)

——40.536.031.8

Net margin, attributable ÷ revenue (%)

48.4462.950.838.778.5

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (HKD Mn)

6,2697,5357,2897,3737,652

Cash and bank balances (HKD Mn)

1,6831,9731,8251,8772,111

Investment properties (HKD Mn)

——2,4892,4964,556

Inventories, properties held for sale (HKD Mn)

1,3401,6911,8021,80375

Interest in joint ventures (HKD Mn)

——700691389

Other financial assets (HKD Mn)

——107133161

Bank borrowings (HKD Mn)

00000

Lease liabilities total (HKD Mn)

4.217.69.88.022.3

Net cash (HKD Mn)

1,6791,9541,8161,8692,089

Shareholders funds (HKD Mn)

6,0057,2186,9717,0637,320

Book value per share (HKD)

16.8520.2619.5719.8220.55

Goodwill and intangibles (HKD Mn)

00000

Working capital (HKD Mn)

2,9933,6763,5513,6392,157

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (HKD Mn)

25.2-282.124.65.069.9

Capex, PP&E (HKD Mn)

7.724.34.16.17.2

Investment property purchases (HKD Mn)

9.463.9105.35.1281.8

Free cash flow, OCF − PP&E capex (HKD Mn)

17.5-306.420.5-1.162.7

Dividends paid (HKD Mn)

89.189.1445.389.189.1

Share buybacks (HKD Mn)

00000

Net change in cash, per S&P (HKD Mn)

678.1-938.1-49.9394.3-363.9

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE, attributable profit ÷ year-end equity (%)

2.018.02.72.34.6

ROA, attributable profit ÷ total assets (%)

1.917.22.62.24.4

Current ratio (x)

17.216.915.817.010.2

Debt to equity, bank debt (x)

00000

Asset turnover, revenue ÷ total assets (x)

0.0390.0370.0510.0570.056

Dividend payout, DPS ÷ EPS (%)

7634475427

Net cash as % of equity (%)

28.027.126.126.528.5

Region revenue (HKD Mn)

Region revenue (HKD Mn)FY2023FY2024FY2025

Hong Kong

374.6422.9427.3

Rest of world

000

District Details

DistrictSegment exposureAssets

Tai Kok Tsui / Mong Kok West (Kowloon)

Property investment, medical

Metro6, Metro Harbour Plaza, Shining Heights, Total HealthCare

Tsim Sha Tsui (Kowloon)

Medical

AMOUR (Mira Place), Total HealthCare (Mira Place), Alliance Medical Centre and physiotherapy (H Zentre)

Cheung Sha Wan (Kowloon)

Property investment

TN Residence (The Symphonie)

Kowloon East (Yau Tong area)

Property investment

The Spectacle arcade

Fanling (New Territories North)

Property investment

Green Code Plaza

Tsuen Wan (New Territories)

Property investment, medical

Tai Hung Fai Centre shops, Total HealthCare

Tuen Mun (New Territories)

Development (JV)

The Royale

Tsing Yi (New Territories)

Shipyard, HQ

Hong Kong Shipyard, head office

North Point / Kwun Tong (harbour)

Ferry

Dangerous-goods ferry route; Bauhinia cruise pier

Valuation Snapshot

MetricValueSource

Share price (HKD)

4.70

StockAnalysis.com (S&P)

52-week change (%)

-3.29

StockAnalysis.com

50-day / 200-day moving average (HKD)

4.85 / 4.96

StockAnalysis.com

Market cap (HKD Mn)

1,674

Computed

Enterprise value (HKD Mn)

-522

S&P (net cash exceeds market cap)

P/E trailing TTM (x)

5.71

S&P (TTM EPS HKD 0.82)

P/E on FY2025 EPS (x)

5.0

Computed

P/B (x)

0.23

Computed on HKD 20.63 BVPS

Price ÷ net cash per share (x)

0.77

Computed on HKD 6.14 net cash per share

EV/EBITDA, EV/Sales

Not meaningful (negative EV)

—

Dividend yield (%)

5.3

Computed on HKD 0.25

Beta, 5-year

0.01

S&P

Average daily volume, 20-day (shares)

138,327

S&P

Analyst coverage / consensus

None identified; no sell-side consensus

—

Credit ratings (Moody's / S&P / Fitch)

Not rated

—

Market Valuation and Share Price

MetricMar 2025Apr 2025Aug 2025Oct 2026

Market cap (HKD Mn)

1,4701,4961,7101,674

Share price (HKD)

4.134.204.804.70

Per-Share Data and Dividends & Capital Returns

MetricFY2021FY2022FY2023FY2024FY2025

Interim DPS (HKD)

0.100.100.100.100.10

Final DPS (HKD)

0.150.150.150.150.15

Special DPS (HKD)

01.00000

Total DPS (HKD)

0.251.250.250.250.25

Total dividends declared (HKD Mn)

89.1445.389.189.189.1

Analyst Conclusions

Management guidance (2026 Interim)

Management gives no numerical guidance. It expects H2 2026 revenue to come primarily from property rentals and bank interest income, ferry losses to shrink after the fare rise effective 27 June 2026, and the medical ecosystem to keep expanding. It will keep the balance sheet liquid while looking for investments with reasonable returns. There is no sell-side consensus.

Analyst framework for FY2026

H1 2026 underlying profit was HKD 73M. H2 benefits from a full period of the fare increase and continued Tai Hung Fai and hostel rent, offset by lower interest income. FY2026 underlying profit therefore plausibly lands at about HKD 140–160M, roughly HKD 0.39–0.45 per share, with revaluations the swing factor. This is an analyst estimate, not company guidance.

Bull case

  1. Asset backing. Shares at HKD 4.70 sit below net cash per share (HKD 6.14) and at 23% of book value (HKD 20.63). The market is effectively ascribing negative value to HKD 4.5B of investment property and to the operating businesses.

  2. Earnings mix shift. Gross rent rose 60% in H1 2026, the medical segment turned profitable, and ferry losses are narrowing on fare increases. Core operating EBITDA excluding interest rose from about HKD 52M (FY2023) to about HKD 72M (FY2025).

  3. Optionality. The HKD 2.2B cash pile, shipyard land conversion and remaining Royale stock offer re-rating catalysts, including a repeat of the FY2022 special dividend if any asset is realised.

Bear case

  1. Value trap. ROE has stayed below 5% outside one-off years. With no buybacks and a flat dividend, controlling-shareholder alignment with minority holders is untested, and the discount has persisted.

  2. Structural declines. Interest income is falling with rates, fuel-truck demand will erode with EV adoption, the shipyard is losing work to the Mainland, and Shining Heights occupancy has slid to 70%.

  3. Reported profit volatility. Reported profit depends on revaluations and JV one-offs, so headline EPS is unreliable. H1 2026 profit attributable fell 34.5% despite revenue growth of 20.5%.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWatch for
FY2026 annual resultsMarch 2027Underlying profit, year-end revaluation, final and possibly special dividend
Ferry fare impactH2 2026 resultsSegment loss trend
Board of Review tax decisionUnknownTax liability quantum
Shipyard land-use studyUnknownPlanning application or rezoning
New acquisitionsOngoingDeployment of cash and yield achieved
Shining Heights re-tenantingOngoingOccupancy recovery from 70%
Royale unsold units (33)OngoingSales or leasing
HIBOR pathOngoingInterest income run-rate
Medical segment profitabilityFY2026Sustained positive margin
Capital return policyAGM May 2027Buyback mandate or special dividend

Concluding analyst verdict

Hong Kong Ferry (Holdings) is no longer a ferry company in any economic sense. It is a debt-free Hong Kong property and cash holding company with a regulated ferry niche and a nascent premium healthcare business attached. Its balance sheet is exceptional for its size. At 30 June 2026, shareholders' funds were HKD 7.35 billion, cash HKD 2.2 billion and investment properties HKD 4.55 billion, against a market capitalisation of about HKD 1.67 billion. Few Hong Kong-listed companies trade below net cash while also owning fully let community retail assets.

The past two years show real operating progress. Converting The Symphonie into the TN Residence youth hostel and buying the Tai Hung Fai shops have lifted recurring rent sharply. The medical business has moved from heavy losses to break-even, and the ferry is recovering costs through three fare increases in 30 months. Against this, interest income is in decline, ferry and shipyard volumes face structural erosion, and reported profit swings with revaluations and JV adjustments. The truer earnings base is about HKD 140–160 million a year of underlying profit, which still implies only about 2% on book equity.

The investment debate therefore turns on capital allocation rather than operations. The persistent discount reflects minority investors' doubt that the controlling shareholder will release value through buybacks, larger distributions or asset realisations. The flat HKD 0.25 dividend, now paid for at least five consecutive years, and the absence of any buyback mandate reinforce that doubt. The FY2022 HKD 1.00 special dividend shows the company will return capital after large realisations, but only episodically.

Verdict: this is a deep-value, low-volatility holding (beta about 0) offering a secure dividend yield of about 5.3% and substantial downside protection. Upside depends on catalysts outside minority investors' control: shipyard land conversion, deployment of the cash pile at attractive yields, or a special distribution. Rating stance: Accumulate for value, low conviction on timing.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleCategoryNotes

Dr. Lam Ko Yin, Colin

Chairman

Executive Director

Long-serving Chairman; senior Henderson Land group executive.

Mr. Li Ning

Director (co-signs results announcements)

Executive Director

Disclosed in 2016 as deemed interested in the Henderson-held block (Note 4 of the substantial shareholders table)

Mr. Lee Gabriel

Group General Manager

Executive Director

Public face of results ("General Manager" in press releases); ED by March 2024 (not on the March 2022 board list)

Mr. Au Siu Kee, Alexander

Director

Non-executive Director

On the board since at least 2022

Mr. Ho Hau Chong, Norman

Director

Independent Non-executive

On the board since at least 2022

Ms. Wong Yu Pok, Marina

Director

Independent Non-executive

Sole female director

Mr. Wu King Cheong

Director

Independent Non-executive

On the board since at least 2022

Mr. Chan Wai Yan, Ronald

Director

Independent Non-executive

Joined between March 2022 and March 2024

Board & Management Changes

DateChange

Between Mar 2022 and Mar 2024

Mr. Lee Gabriel appointed Executive Director; Mr. Chan Wai Yan, Ronald appointed INED

8 Dec 2023

Mr. Chow Tung Ming appointed Company Secretary and authorised representative, succeeding Mr. Yuen Wai Kuen (retired)

17 Mar 2025

Death of Dr. Lee Shau Kee (director 1981–2020)

Between Mar 2025 and Aug 2026

Mr.

Major Shareholders

HolderShares%As atSource

Henderson Land Development Co. Ltd (through Pataca Enterprises, via Wiselin Investment 48,817,090; Graf Investment 23,400,000; Mount Sherpa 23,400,000; Paillard Investment 23,400,000)

119,017,09033.41

31 Dec 2016 (latest verified)

Annual Report 2016

Henderson Development Ltd; Hopkins, Rimmer and Riddick (Cayman) trusts

Same block (deemed)

33.412,016

Annual Report 2016

Free float (S&P estimate)

231.03M

64.8

Oct 2026

StockAnalysis.com

Institutional ownership (S&P estimate)

—1.25

Oct 2026

StockAnalysis.com

Competitive Landscape

Competitors by Segment

SegmentCompetitorPositioning against HKF

Ferry (harbour/outlying)

Star Ferry (Wharf group, private)

Passenger cross-harbour icon; no dangerous-goods service

Ferry

Sun Ferry (formerly New World First Ferry)

Took over HYF's franchised routes in 2000; passenger focus

Ferry

Hong Kong & Kowloon Ferry (HKKF)

Outlying-island passenger routes

Ferry / marine leisure

Shun Tak Holdings (0242.HK; TurboJET JV)

Cross-boundary ferries plus property; larger and more diversified

Harbour cruises

Water Taxi / Aqua Luna and other private cruise operators

Leisure harbour-cruise competitors to Bauhinia

Shipyard

Mainland GBA shipyards; local private yards (e.g. Cheoy Lee, Yiu Lian Dockyards)

Lower-cost Mainland yards are taking maintenance work, per HKF

Community retail landlord

Link REIT (0823.HK)

Dominant owner of community malls; scale advantage

Community retail landlord

Henderson Land (0012.HK), Sun Hung Kai Properties (0016.HK), New World / K11

Large developer-landlords near HKF's malls

Diversified small-cap property

Kowloon Development (0034), Chinese Estates (0127), Wang On Properties (1243), CSI Properties (0497)

Comparable small/mid-cap HK property names

Medical aesthetics

Perfect Medical Health Management (1830.HK); Mainland GBA aesthetics clinics

Larger listed aesthetics chain; GBA price competition

Medical / specialist

UMP Healthcare (0722.HK); private hospital outpatient services (e.g. HK Sanatorium, Gleneagles)

Specialist networks; hospitals cutting outpatient fees

Pain / chiropractic

Independent chiropractic and physiotherapy chains

Fragmented market

Peer Comparison FY2025

MetricHKF (FY2025)Link REIT

Revenue (HKD Mn)

427—

Revenue growth (%)

1.0—

Gross margin (%)

38.2—

R&D intensity (%)

0—

Balance sheet

Net cash about HKD 2.1B

Leveraged REIT

Overlap with HKF

—

Community retail

“—” = not publicly disclosed.

Recent Developments

Entries from just before the window are included for context.

There were no layoffs, guidance revisions, regulatory sanctions or new litigation in the window, other than the ongoing tax appeal.

Company Snapshot

$54.9M

Revenue

363

Employees

1923

Founded

New Territories, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Fortress balance sheet. The group has had no bank borrowings in any year from FY2021 to H1 2026, and held HKD 2,205M of cash at 30 June 2026, about 132% of market capitalisation.
  • Regulatory exclusivity. It is the only Hong Kong operator of vehicular and dangerous-goods vehicular ferries (2025 Results), and has won fare rises in Jan 2024, Apr 2025 and Jun 2026.
  • High-occupancy community malls. Metro6 was 100% let and Metro Harbour Plaza 93% and Green Code Plaza 94% let at Jun 2026; Tai Hung Fai was 100% let within three months of acquisition.
  • Recurring-income conversion. The Symphonie's move to investment property lifted H1 2026 gross rent 60% to HKD 97M.
  • Medical turnaround. Segment losses narrowed from HKD 37.8M (FY2023) to HKD 4.4M (FY2025), and the segment made a HKD 1.3M profit in H1 2026.
  • Consistent dividends. HKD 0.25 has been paid in every year from FY2021 to FY2025, plus a HKD 1.00 special for FY2022. The trailing yield is about 5.3%.
  • Strong governance compliance record. Full CG Code compliance has been reported every year, with unqualified KPMG opinions.

Weaknesses

  • Low returns. ROE was 2.3% in FY2024 and 4.6% in FY2025, the latter flattered by a one-off. TTM ROIC is 2.37% (S&P).
  • Loss-making ferry and shipyard. Segment losses were HKD 7.6M (FY2023), HKD 8.0M (FY2024) and HKD 20.1M (FY2025); shipyard revenue fell 12% in FY2025.
  • Earnings depend on revaluations and one-offs. Valuation gains moved from HKD 42.3M to HKD 2.0M to HKD 50.3M to HKD 6.6M (H1 2026). FY2022 and FY2025 profits were inflated by JV items.
  • Rising cost base. Administrative expenses grew 53% from FY2023 to FY2025 (HKD 75.0M to HKD 114.6M).
  • Weak operating cash flow relative to profit. FY2024 OCF was HKD 5.0M against profit attributable of HKD 163.9M (S&P basis).
  • Weakening asset. Shining Heights arcade occupancy fell from 95% to 70% in 18 months.

Opportunities

  • Deploying cash at cyclical lows. Management explicitly cites the sharp fall in commercial valuations; the HKD 2.2B war chest could support several Tai Hung Fai-scale deals.
  • Shipyard land-use conversion. The Tsing Yi site of about 200,000 sq ft could be redeveloped or rezoned to unlock value.
  • Policy tailwinds. The government's healthcare-hub agenda, youth hostel scheme, Mega Event Economy and yacht-hub measures each map onto an HKF business.
  • Healthcare scale-up. AMOUR revenue grew 138% in FY2024; a third pain centre has opened; equipment leasing provides annuity income.
  • Residential rental boom. Rents hit record highs in H1 2026, and the hostel's occupancy-linked rent could rise further.
  • Narrowing the valuation gap. The stock trades at P/B 0.23 with negative EV, so capital returns or asset realisations could re-rate the shares.

Threats

  • Falling interest rates. Interest income dropped from HKD 99.1M (FY2023) to HKD 64.3M (FY2025), and was down 27% YoY in H1 2026.
  • EV adoption. Management acknowledges a structural decline in dangerous-goods ferry traffic (2026 Interim).
  • Retail structural shifts. Online shopping, northbound consumption and changing visitor patterns are flagged as significant risks (2026 Interim).
  • Fuel cost inflation. Rising oil prices from Middle East conflict increased ferry losses in H1 2026.
  • Cross-border medical competition. Price-driven migration of check-ups, dental and aesthetics to the GBA, plus private hospital outpatient discounts.
  • Tax dispute. The IRD disallowed capital expenditure deductions for a subsidiary across assessment years 2001/02 to 2015/16. The appeal was heard in Jul–Aug 2024 and the decision is pending, so an adverse outcome is possible.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
12 Mar 2025Binding MOU to lease all 262 Symphonie units to a non-profitPivot from sales to recurring rent
17 Mar 2025Death of Dr. Lee Shau KeeFounder-era Henderson link ends
18 Mar 2025FY2024 results: revenue HKD 423M (+12.9%), underlying profit HKD 158M (+10%), EPS HKD 0.46, DPS HKD 0.25Baseline year
12 Apr 2025New North Point–Kwun Tong ferry fares effectivePartial cost recovery
30 May 2025AGM; final dividend HKD 0.15 approvedRoutine
Jun 2025TN Residence rent commencesStarts the H1 2026 rent surge
23 Jun 2025FY2024 final dividend paidShareholder return
Mid-2025Tai Hung Fai shop acquisition announced (HKD 260M)First sizeable acquisition in years
Aug 2025Physiotherapy centre opens at H ZentreEcosystem build
19 Aug 2025Board meeting approves H1 2025 results–
20 Aug 2025H1 2025: revenue HKD 199M (−5%), profit attributable HKD 122M (+36%), underlying HKD 69M (−19%); interim DPS HKD 0.10Revaluation-driven profit
Sep 2025New dangerous-goods ferry fare application lodgedCost recovery
30 Sep 2025Tai Hung Fai acquisition completedRent from Q4 2025
Nov 2025Specialist centre rebranded Alliance Medical CentreBrand revitalisation
Dec 2025All Tai Hung Fai shops letDe-risks the acquisition
Jan 2026Third Total HealthCare centre (Tsuen Wan) begins trial operationsExpansion
Feb 2026AMOUR wins Hong Kong Emerging Service Brand awardBrand
2 Mar 2026Monthly return: no change in 356.27M shares; float above 25%Routine
19 Mar 2026FY2025 results: profit attributable HKD 335M (+105%), underlying HKD 284M (+80%), EPS HKD 0.94, DPS HKD 0.25JV one-off and revaluation
Mar 2026Disclosure that the IRD tax appeal decision from the Board of Review is still pendingContingent tax exposure
Apr 2026Symphonie car park starts operatingIncremental income
29 May 2026AGMRoutine
23 Jun 2026FY2025 final dividend (HKD 0.15) paidShareholder return
Jun 2026Transport Department approves ferry fare increaseNarrows losses
27 Jun 2026New ferry fares effectiveH2 2026 benefit
Jul 2026Pet-friendly themed Bauhinia cruise launchedLeisure innovation
3 Aug 2026Board meeting notice for interim results–
19 Aug 2026H1 2026: revenue HKD 240M (+20.5%), profit attributable HKD 80M (−34.5%), underlying HKD 73M (+5.7%), interim DPS HKD 0.10; headcount about 363Rent and medical up; revaluation down
Sep 2026Interim Report 2026 published–
28 Sep 2026Interim dividend paid (record date 14 Sep 2026)Shareholder return

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

8 charts
Income Statement: Revenue & Gross Profit: Revenue rose from HKD 244.2 Mn in FY2021 to HKD 427.3 Mn in FY2025.
Hong Kong Ferry (Holdings) Company Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2021FY2022FY2023FY2024FY2025
Revenue244.2280.6374.6422.9427.3
Gross profit79.6100.9140.5164.1163.1

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. HKEX: 2025 Results Announcement, 19 Mar 2026 ( (hkexnews.hk)
  2. HKEX: 2026 Interim Results Announcement, 19 Aug 2026 (…/2026/0819/2026081901301.pdf)
  3. HKEX: 2024 Results Announcement, 18 Mar 2025 (…/2025/0318/2025031801823.pdf)
  4. HKEX: Board meeting notices of 3 Mar 2022, 4 Mar 2024 and 3 Aug 2026; positive profit alert of 21 Nov 2022; FY2022 final and special dividend notices of 17 Mar 2023; AGM poll results of 31 May 2022 and 31 May 2023; Interim Reports 2021 and 2023
  5. HKEX: Annual Reports 2001, 2005 and 2006 (Report of the Directors); Annual Reports 2015 and 2016 (substantial shareholders, via HK historical texts archive)
  6. EQS Newswire press releases for FY2023 interim and annual, FY2024 interim and annual, and FY2025 interim results
  7. Baird Maritime, H1 2025 results coverage
  8. Tiger Brokers / Bulletin Express: monthly return (Feb 2026) and Interim Report 2026 summary
  9. FilingReader: H1 2026 summary
  10. StockAnalysis.com (S&P Global Market Intelligence): income statement, balance sheet, cash flow and statistics (accessed Oct 2026)
  11. ET Net: FY2020 to FY2024 income history; TipRanks: market caps and income statement
  12. Wikipedia: Hong Kong Ferry and Hongkong and Yaumati Ferry entries; Industrial History of Hong Kong (HYF Golden Jubilee timeline); Lingnan University MPhil thesis (Sham Wai Chi, 2007)
  13. Similarweb / press reports (Tai Hung Fai vendor identity)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.